No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study ShowsBenzinga • 07/28/21
Hutchmed Stock Gains On Kick Starting Mid-Stage Gastric Cancer Trial With AstraZeneca's OrpathysBenzinga • 07/28/21
AstraZeneca says Alexion receives recommendation to use rare blood disorder drug in kidsProactive Investors • 07/26/21
Real-World Data In Canada Shows AstraZeneca's COVID-19 Jab Is Over 80% Effective Against VariantsBenzinga • 07/23/21
Study Finds Pfizer And AstraZeneca Vaccines Effective Against The Delta Variant — As Long As You Get Both DosesForbes • 07/21/21
Alexion's Ultomiris Sales Almost Doubles In 1H 2021 As $39B AstraZeneca Deal LoomsBenzinga • 07/20/21
Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready Monoclonal Antibody, from AstraZenecaPRNewsWire • 07/19/21
AstraZeneca receives green light for small cell lung cancer treatment in ChinaProactive Investors • 07/19/21
AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal, But Is It a Good Deal?The Motley Fool • 07/17/21
With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?The Motley Fool • 07/17/21
